Back
Galera Therapeutics, Inc. 10K Form
Sell
32
GRTX
Galera Therapeutics, Inc.
Last Price:
$0.02
Seasonality Move:
-29.3%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GRTX News And Ratings
See the #1 stock for the next 7 days that we like better than GRTX
GRTX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-757K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-1.94 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.13020 |
|---|---|
| Net Income (TTM): | $-9M |
| Gross Margin: | $-20K |
| Return on Equity: | 0% |
| Return on Assets: | -119.14% |
Galera Therapeutics, Inc. Earnings Forecast
Key Galera Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 8 years have been positive in 5 years.
Galera Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GRTX |
| CUSIP: | 36338D |
| Website: | galeratx.com |
Debt
| Debt-to-Equity Ratio: | -1.03 |
|---|---|
| Current Ratio: | 8.2 |
| Quick Ratio: | 7.48 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GRTX Technical Analysis vs Fundamental Analysis
Sell
32
Galera Therapeutics, Inc. (GRTX)
is a Sell
Is Galera Therapeutics, Inc. a Buy or a Sell?
-
Galera Therapeutics, Inc. stock is rated a SellThe current Galera Therapeutics, Inc. [GRTX] share price is $0.02. The Score for GRTX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.